Multi-omics analysis reveals the protective effect of a novel bioactive peptide (BP1) in cardiomyopathy using zebrafish model
Medicinal plants have been used in traditional healthcare systems and drug discovery since ancient times due to the storage of natural products, including bioactive metabolites and peptides. Bioactive peptides (BPs) are reported to have diverse therapeutic potential and are used for the treatment/prevention of many lifelong diseases, including cardiovascular. In our previous work, we isolated and characterized a bioactive peptide ASGLCPEEAVPRR (BP1) from Picrorhiza kurroa and hypothesized that BP1 possesses angiotensin-converting enzyme (ACE) inhibitory activity that has a cardioprotective role; however, a system-level understanding of its cardioprotective and metabolic control is needed to validate the hypothesis. Here, we investigated the cardioprotective effect of BP1 in zebrafish larva and adult models of isoproterenol (ISO) and doxorubicin (DOX) induced cardiac damage. Following the treatment, the cardiac morphology, cardiac functional parameters, transcriptome and metabolome were studied. Results indicated that treatment with BP1 significantly reduced ISO-induced cardiac dysfunction, restored normal cardiac morphology and function in zebrafish larvae. Similarly, BP1 pretreatment effectively mitigated DOX-induced pathological changes in the myocardium of zebrafish. Transcriptomic and weighted gene co-expression network analysis (WGCNA) analysis showed attenuation in the expression of genes associated with protein synthesis, metabolic pathways, signaling pathways, and cardiac muscle contraction, among other following BP1 treatment in DOX-induced cardiotoxicity model. Untargeted metabolomics revealed metabolic pathways like sphingolipid, riboflavin, and glutathione metabolism, among others, involved in attenuating DOX-induced cardiotoxicity by BP1. Our result concluded that BP1 treatment shows cardioprotection in zebrafish via targeting multiple pathogenic pathways involved in cardiotoxicity.